Counterclaimant Valeant Pharmaceuticals International Inc. / Allergan / Pershing Square Capital Management L.P. / Counterclaimant PS Fund 1 LLC / PS Fund 1 LLC / KIRKLAND & ELLIS LLP / Value / VALEANT PHARMACEUTICALS / Howard Hughes Corporation / Counterclaim-Defendant Allergan Inc. / Pershing Square Holdings Ltd. / Glass Lewis / Pershing Square II L.P. / SANTA ANA 11 12 13 14 ALLERGAN INC. / General Growth Properties / Fortune Brands / Valeant Pharmaceuticals International Inc. / Pershing Square International Ltd. / Delaware Limited Partnership / Counterclaimant AGMS Inc. / /
Country
Cayman Islands / Canada / Guernsey / /
Currency
USD / / /
Event
Judicial Event / M&A / General or Shareholder Meeting / Funding / /
Facility
COUNTERCLAIMS OF VALEANT AND PERSHING SQUARE / Pershing Square / United States District Court / /
IndustryTerm
Delaware law / companies making products / pharmaceuticals / related subsidiaries / /
MarketIndex
S&P 500 / /
Movie
Mr. Jones / /
Organization
U.S. Securities and Exchange Commission / United States District Court for the Central District of California / /
Person
William Ackman / Peter J. McDonnell / Henri A. Termeer / Louis J. Lavigne Jr. / Deborah Dunsire / Trevor M. Jones / Louis J. Lavigne / David O. Carter / Russell T. Ray / David Pyott / Michael R. Gallagher / Timothy D. Proctor / Michael Shipley / / /
Position
Chief Executive Officer 15 / Additional counsel / President / Chief Executive Officer / Chairman and CEO / member of the Board / registered investment advisor / CEO / Chairman of the 17 Board / member of the Board of Directors / Chairman / board member / member of Board of Directors / Chairman / Board of Directors / member of 24 Board / /
Case 8:14-cv[removed]DOC-AN Document[removed]Filed[removed]Page 1 of 45 Page ID #:[removed]